Lv31
250 积分 2021-07-06 加入
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
29分钟前
待确认
Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma
2小时前
已完结
Immunotherapies for hepatocellular carcinoma
20天前
已完结
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
21天前
已关闭
超高危动脉粥样硬化性心血管疾病患者血脂管理中国专家共识
25天前
已完结
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
1个月前
已完结
A Retrospective, Epidemiological Review of Type 2 Diabetes Mellitus in a Military Population
2个月前
已关闭
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
3个月前
已完结
Association of circulating tumor DNA dynamics with clinical outcomes in the adjuvant setting for patients with colorectal cancer from an observational GALAXY study in CIRCULATE-Japan
3个月前
已关闭
AKR1D1 suppresses liver cancer progression by promoting bile acid metabolism-mediated NK cell cytotoxicity
4个月前
已完结
皖公网安备34019202002308
